THIOTEPA
Generic: THIOTEPA
Dr.Reddy's Laboratories Inc.Manufacturer
INTRACAVITARY, INTRAVENOUS, INTRAVESICALRoute
THIOTEPAActive Substance
2018-05-04Original Approval
THIOTEPA is FDA application ANDA210337, sponsored by DR REDDYS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
1,213 reports
2
FEBRILE NEUTROPENIA
817 reports
3
MUCOSAL INFLAMMATION
793 reports
4
PRODUCT USE IN UNAPPROVED INDICATION
595 reports
5
DRUG INEFFECTIVE
554 reports
6
CYTOMEGALOVIRUS INFECTION
530 reports
7
PYREXIA
509 reports
8
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
460 reports
9
ACUTE GRAFT VERSUS HOST DISEASE
458 reports
10
CYTOMEGALOVIRUS INFECTION REACTIVATION
454 reports